Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 147

1.

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.

Habibi M, Mirfakhraie R, Khani M, Rakhshan A, Azargashb E, Pouresmaeili F.

Gene. 2017 Nov 15;634:47-52. doi: 10.1016/j.gene.2017.08.038. Epub 2017 Sep 4.

PMID:
28882566
2.

Architecture of the human interactome defines protein communities and disease networks.

Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW.

Nature. 2017 May 25;545(7655):505-509. doi: 10.1038/nature22366. Epub 2017 May 17.

3.

Implication of UGT2B15 Genotype Polymorphism on Postoperative Anxiety Levels in Patients Receiving Lorazepam Premedication.

Mijderwijk H, Klimek M, van Beek S, van Schaik RH, Duivenvoorden HJ, Stolker RJ.

Anesth Analg. 2016 Nov;123(5):1109-1115.

PMID:
27622723
4.

Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.

Hu DG, Selth LA, Tarulli GA, Meech R, Wijayakumara D, Chanawong A, Russell R, Caldas C, Robinson JL, Carroll JS, Tilley WD, Mackenzie PI, Hickey TE.

Cancer Res. 2016 Oct 1;76(19):5881-5893. Epub 2016 Aug 5.

5.

Genetic polymorphism of UDP-glucuronosyltransferase (UGT2B15) and glucuronidation of paracetamol in healthy population.

Mehboob H, Iqbal T, Jamil A, Khaliq T.

Pak J Pharm Sci. 2016 May;29(3 Suppl):1037-41.

PMID:
27383482
6.

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.

Sutiman N, Lim JS, Muerdter TE, Singh O, Cheung YB, Ng RC, Yap YS, Wong NS, Ang PC, Dent R, Schroth W, Schwab M, Khor CC, Chowbay B.

Clin Pharmacokinet. 2016 Oct;55(10):1239-50. doi: 10.1007/s40262-016-0402-7.

PMID:
27098059
7.

Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing.

Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, Wang X, Ma HL, Huang CM, Yang Y, Huang N, Jiang GB, Wang HL, Zhou Q, Wang XJ, Zhao YL, Yang YG.

Mol Cell. 2016 Feb 18;61(4):507-519. doi: 10.1016/j.molcel.2016.01.012. Epub 2016 Feb 11. Erratum in: Mol Cell. 2016 Mar 17;61(6):925.

8.

DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.

Ng HY, Ko JM, Yu VZ, Ip JC, Dai W, Cal S, Lung ML.

Int J Cancer. 2016 Jun 15;138(12):2940-51. doi: 10.1002/ijc.30034. Epub 2016 Feb 26.

10.

A human interactome in three quantitative dimensions organized by stoichiometries and abundances.

Hein MY, Hubner NC, Poser I, Cox J, Nagaraj N, Toyoda Y, Gak IA, Weisswange I, Mansfeld J, Buchholz F, Hyman AA, Mann M.

Cell. 2015 Oct 22;163(3):712-23. doi: 10.1016/j.cell.2015.09.053. Epub 2015 Oct 22.

11.

Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.

Margaillan G, Lévesque É, Guillemette C.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):85-93. doi: 10.1016/j.jsbmb.2015.09.021. Epub 2015 Sep 15.

PMID:
26385605
12.

Structural Basis for the Discriminative Recognition of N6-Methyladenosine RNA by the Human YT521-B Homology Domain Family of Proteins.

Xu C, Liu K, Ahmed H, Loppnau P, Schapira M, Min J.

J Biol Chem. 2015 Oct 9;290(41):24902-13. doi: 10.1074/jbc.M115.680389. Epub 2015 Aug 28.

13.

Histopathology of melanosis coli and determination of its associated genes by comparative analysis of expression microarrays.

Li XΑ, Zhou Y, Zhou SΧ, Liu HR, Xu JM, Gao L, Yu XJ, Li XH.

Mol Med Rep. 2015 Oct;12(4):5807-15. doi: 10.3892/mmr.2015.4126. Epub 2015 Jul 27.

14.

The BioPlex Network: A Systematic Exploration of the Human Interactome.

Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wühr M, Chick J, Zhai B, Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA, Harper JW, Gygi SP.

Cell. 2015 Jul 16;162(2):425-440. doi: 10.1016/j.cell.2015.06.043.

15.

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

Romero-Lorca A, Novillo A, Gaibar M, Bandrés F, Fernández-Santander A.

PLoS One. 2015 Jul 15;10(7):e0132269. doi: 10.1371/journal.pone.0132269. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0140921.

16.

SR protein kinases promote splicing of nonconsensus introns.

Lipp JJ, Marvin MC, Shokat KM, Guthrie C.

Nat Struct Mol Biol. 2015 Aug;22(8):611-7. doi: 10.1038/nsmb.3057. Epub 2015 Jul 13.

PMID:
26167880
17.

Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.

Wijayakumara DD, Hu DG, Meech R, McKinnon RA, Mackenzie PI.

J Pharmacol Exp Ther. 2015 Sep;354(3):417-25. doi: 10.1124/jpet.115.226118. Epub 2015 Jul 10.

18.

Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cells.

Chanawong A, Hu DG, Meech R, Mackenzie PI, McKinnon RA.

Drug Metab Dispos. 2015 Jun;43(6):889-97. doi: 10.1124/dmd.114.062935. Epub 2015 Mar 20.

19.

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

Diner BA, Lum KK, Javitt A, Cristea IM.

Mol Cell Proteomics. 2015 Sep;14(9):2341-56. doi: 10.1074/mcp.M114.047068. Epub 2015 Feb 18.

20.

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

Li X, Wang W, Wang J, Malovannaya A, Xi Y, Li W, Guerra R, Hawke DH, Qin J, Chen J.

Mol Syst Biol. 2015 Jan 21;11(1):775. doi: 10.15252/msb.20145504.

Supplemental Content

Support Center